Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
21.10B
Market cap21.10B
Price-Earnings ratio
22.26
Price-Earnings ratio22.26
Dividend yield
1.66%
Dividend yield1.66%
Average volume
1.29M
Average volume1.29M
High today
$192.26
High today$192.26
Low today
$189.22
Low today$189.22
Open price
$191.39
Open price$191.39
Volume
868.12K
Volume868.12K
52 Week high
$197.55
52 Week high$197.55
52 Week low
$148.70
52 Week low$148.70

Stock Snapshot

As of today, Quest Diagnostics(DGX) shares are valued at $189.69. The company's market cap stands at 21.1B, with a P/E ratio of 22.26 and a dividend yield of 1.7%.

On 2025-11-28, Quest Diagnostics(DGX) stock moved within a range of $189.22 to $192.26. With shares now at $189.69, the stock is trading +0.3% above its intraday low and -1.3% below the session's peak.

Trading volume for Quest Diagnostics(DGX) stock has reached 868.12K, versus its average volume of 1.29M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $148.70.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $148.70.

DGX News

The Motley Fool 8h
Quest Q3 2025 Earnings Call Transcript

Image source: The Motley Fool. Oct. 21, 2025 at 12 a.m. ET Call participants Chairman, Chief Executive Officer, and President — James Davis Executive Vice Pres...

Quest Q3 2025 Earnings Call Transcript
Nasdaq 19h
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?

In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, each with its own niche. Hologic focu...

HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?
Nasdaq 4d
Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?

Quest Diagnostics Inc.’s DGX continued momentum in the base business is poised to help it grow in the upcoming quarters. The ongoing adoption of the highly spec...

Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?

Analyst ratings

55%

of 22 ratings
Buy
40.9%
Hold
54.5%
Sell
4.5%

More DGX News

Simply Wall St 5d
A Look at Quest Diagnostics Valuation Following Strong Q3 2025 Results and Upgraded Outlook

Quest Diagnostics (DGX) caught investors’ attention after it reported third-quarter 2025 results that beat expectations, showing a year-over-year jump in both e...

A Look at Quest Diagnostics Valuation Following Strong Q3 2025 Results and Upgraded Outlook

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.